Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 2/20 | 0.32 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 3/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12330057 | 0.72 | TSHR (0.43) | CYP2C19TSHRMEN1KMT2ASLC6A2 | |
| SCHEMBL3228648 | 0.70 | TSHR (0.42) | CYP2C19TSHRMEN1KMT2ASLC6A2 | |
| SCHEMBL15782443 | 0.69 | — | — | |
| SCHEMBL23729127 | 0.69 | — | — | |
| SCHEMBL21928749 | 0.69 | — | — | |
| SCHEMBL4612040 | 0.68 | TSHR (0.39) | CYP2C19TSHRMEN1KMT2ASLC6A2 | |
| SCHEMBL29626010 | 0.68 | TSHR (0.39) | CYP2C19TSHRMEN1KMT2ASLC6A2 | |
| SCHEMBL9588592 | 0.66 | — | — | |
| SCHEMBL9587789 | 0.66 | TSHR (0.41) | CYP2C19TSHRSLC6A2ADRA1ASLC6A3 | |
| SCHEMBL3504323 | 0.63 | TSHR (0.42) | CYP2C19TSHRMEN1KMT2ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190155975-A9 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2019-05-23 | — | — | US | claimed |
| US-10240108-B2 | Particles for malodor reduction | THE PROCTER & GAMBLE COMPANY (US) | 2019-03-26 | — | — | US | claimed |
| EP-3365418-A2 | PARTICLES FOR MALODOR REDUCTION | The Procter and Gamble Company (US) | 2018-08-29 | — | — | EP | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-20180004875-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2018-01-04 | — | — | US | claimed |
| US-20170333591-A9 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2017-11-23 | — | — | US | claimed |
| US-20170275564-A1 | PARTICLES FOR MALODOR REDUCTION | PROCTER & GAMBLE (US) | 2017-09-28 | — | — | US | claimed |
| US-20170249408-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2017-08-31 | — | — | US | claimed |
| US-20170249407-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | THE PROCTER & GAMBLE COMPANY | 2017-08-31 | — | — | US | claimed |
| EP-3197425-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | The Procter and Gamble Company (US) | 2017-08-02 | — | — | EP | claimed |
| US-20160090556-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049395-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-7713922-B2 | Perfume compositions | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2010-05-11 | — | — | US | claimed |
| US-20090137450-A1 | Perfume Compositions | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2009-05-28 | — | — | US | claimed |
| EP-1926530-A1 | PERFUME COMPOSITIONS | Quest International Services B.V. (NL) | 2008-06-04 | — | — | EP | claimed |
| WO-2007034187-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2007-03-29 | — | — | WO | claimed |
| WO-1993021296-A1 | AQUEOUS LIQUID BLEACH COMPOSITIONS WITH FLUORESCENT WHITENING AGENT AND POLYVINYL PYRROLIDONE OR POLYVINYL ALCOHOL | THE PROCTER & GAMBLE COMPANY (US) | 1993-10-28 | — | — | WO | claimed |
| WO-1993021295-A1 | LIQUID OR GEL BLEACHING COMPOSITION CONTAINING AMIDOPEROXYACID BLEACH AND PERFUME | THE PROCTER & GAMBLE COMPANY (US) | 1993-10-28 | — | — | WO | claimed |
| US-5248434-A | Stability | THE PROCTOR & GAMBLE COMPANY (US) | 1993-09-28 | — | — | US | claimed |
| US-5234617-A | Cleaning, bleaching fabrics | Hunter, Kathleen B. (US) | 1993-08-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170249408-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | LPO, QDPR, TYR | CYP2C19 352/4885TSHR 4094/4885MEN1 3913/4885 |
| US-20170249407-A1 | Antiperspirant and Deodorant Compositions Comprising Malodor Reduction Compositions | LPO, QDPR, TYR | CYP2C19 357/4885TSHR 4013/4885MEN1 3949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.